Price movement over the last 24 hours
AKR Corporindo Tbk vs Clipan Finance Indonesia Tbk. — how do they compare? AKR Corporindo Tbk trades at Rp1,320 (market cap 26T, 15.27M 24h volume), while Clipan Finance Indonesia Tbk. trades at Rp324 (market cap 1.3T, 1.31M 24h volume). The key difference: AKR Corporindo Tbk is far larger — about 20× Clipan Finance Indonesia Tbk.'s market cap, and AKR Corporindo Tbk is more actively traded (15.27M versus 1.31M). Which is the better fit depends on your goals.
| AKRA | CFIN | |
|---|---|---|
Market Cap | 26T | 1.3T |
Volume | 15.27M | 1.31M |
Lot | 152.7K | 13.08K |
Turnover | 20.11B | 424.77M |
Average Price | 1,316.87 | 324.87 |
Value | 20.11B | 424.77M |
Indicative Equilibrium Price | 1,320 | 324 |
Indicative Equilibrium Volume | 4.56K | 470 |
Trailing returns across standard periods
Latest headlines on both assets
PT AKR Corporindo Tbk was established in Surabaya on November 28, 1977 based on the Notarial Deed No. 46 of Sastra Kosasih, S.H., which was amended by Notarial Deed No. 26 of the same notary dated April 12, 1978 . In 2004, the Company changed its name from PT Aneka Kimia Raya Tbk to PT AKR Corporindo Tbk. PT Aneka Kimia Raya is the largest chemical distributor in Indonesia. The Company is dominantly positioned within the industry, distributing more than 40 chemical products. The Company is foreign investment.
Read more on AKRA →PT Clipan Finance Indonesia Tbk (the Company) was established on January 15, 1982 based on the notarial deed No.47 of Kartini Muljadi SH. The Deed of establishment was approval by the Ministry of Justice with his decision letter No. C2-396-HT.01Th.82 on August 2, 1982 and was published on State Gazette No.79 dated October 1, 1982, Supplement No.1189. The article of association have been change several times, most recently on June 29 1998 concerning among others, the change in the Authorized capital and par value of share. The Company is located in Jakarta and the branches is in Denpasar. The Company is affiliated by Panin Group.
Read more on CFIN →